腹股沟疝修补术后补片性能上市后监测
该回顾性队列研究纳入2010年1月至2023年6月在Kaiser Permanente接受择期补片腹股沟疝修补的成人,应用DELTA安全监测方法回顾性分析再手术率,发现Surgipro、Kugel、Parietex等补片触发安全警报,提示该方法可用于补片上市后自动化监测。
要点
- DELTA方法可回顾性识别腹股沟疝补片再手术安全信号。
- Surgipro、Kugel、Parietex等补片触发再手术安全警报。
- 常用补片ProGrip、Parietex(开放)、PerFix未触发警报。
核心结论
- DELTA方法回顾性应用可触发多个腹股沟疝补片的安全警报,值得进一步调查。
- 该监测系统可能为补片植入物上市后自动化监测提供机会。
研究设计与样本
- 回顾性队列研究,纳入2010年1月至2023年6月在Kaiser Permanente接受择期补片腹股沟疝修补的成人。
- 共分析124 458例修补、104 241例患者,由784名外科医生在38家医院完成。
- 识别14种开放和12种微创补片品牌,每种补片按年龄、BMI、性别和ASA分级1:1倾向评分匹配。
- 主要结局为复发再手术,每季度评估,随访至会员终止、死亡或2023年6月30日。
主要发现
- 最常用的3种开放补片未触发警报:ProGrip再手术率1.4%(RR=1.01,95%CI 0.87-1.17),Parietex 1.6%(RR=0.96,95%CI 0.79-1.16),PerFix 1.8%(RR=0.98,95%CI 0.80-1.21)。
- Surgipro触发警报:再手术率1.7%(RR=1.27,95%CI 1.00-1.62),首次使用后9个季度。
- Kugel触发警报:再手术率2.5%(RR=2.05,95%CI 1.19-3.54),9个季度。
- 微创补片中Parietex触发警报:再手术率2.1%(RR=1.59,95%CI 1.31-1.92),27个季度;ProGrip和3DMax未触发。
- Parietene、Surgipro、ProLite也触发警报,再手术率分别为1.7%、5.0%、1.2%。
关键数值与推荐
- 安全警报触发标准:目标补片累积再手术率超过对照组95%CI上限连续3个或以上季度。
临床怎么用
- 临床可关注触发警报的补片品牌(如Surgipro、Kugel、Parietex等)的再手术风险。
- DELTA方法可作为补片上市后监测工具,辅助识别潜在安全信号。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: As more mesh products are approved for inguinal hernia repair, postmarket surveillance is needed to assess their real-world performance. OBJECTIVE: To apply the Data Extraction and Longitudinal Trend Analysis (DELTA) safety surveillance methodology to a large inguinal hernia mesh database in a retrospective manner for proof of concept and to assess its ability to identify safety alerts for reoperation for hernia recurrence. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included adults who underwent elective mesh-based inguinal hernia repair between January 2010 and June 2023 within Kaiser Permanente, a US-based integrated health care system. Patients were followed up until membership termination, death, or the study end date (June 30, 2023). Data analysis was completed from June 2023 to December 2024. EXPOSURES: A total of 14 open and 12 minimally invasive (MIS) mesh brands were identified. MAIN OUTCOMES AND MEASURES: The primary outcome measure was reoperation for recurrence, evaluated quarterly over time after the first point of implantation. Each mesh of interest was 1:1 propensity score matched to different meshes based on patient age, body mass index, sex, and American Society of Anesthesiologists (ASA) classification. A safety alert was triggered if the cumulative reoperation rate for the mesh of interest exceeded the 95% confidence interval upper limit of the comparison group for 3 or more consecutive quarters. RESULTS: The study sample included 124 458 repairs in 104 241 patients performed by 784 surgeons at 38 hospitals. Mean (SD) patient age was 58.9 (15.5) years, and 9234 patients (7.4%) were female. None of the 3 most-used open meshes triggered safety alerts: ProGrip (reoperation rate = 1.4%; relative risk [RR] = 1.01; 95% CI, 0.87-1.17), Parietex (reoperation rate = 1.6%; RR = 0.96; 95% CI, 0.79-1.16), and PerFix (reoperation rate = 1.8%; RR = 0.98; 95% CI, 0.80-1.21). Surgipro (reoperation rate = 1.7%; RR = 1.27; 95% CI, 1.00-1.62; 9 quarters after first use) and Kugel (reoperation rate = 2.5%; RR = 2.05; 95% CI, 1.19-3.54; 9 quarters) triggered alerts. Of the 3 highest-volume MIS meshes, Parietex triggered an alert (reoperation rate = 2.1%; RR = 1.59; 95% CI, 1.31-1.92; 27 quarters); ProGrip (reoperation rate = 0.9%; RR = 0.47; 95% CI, 0.37-0.60) and 3DMax (reoperation rate = 1.2%; RR = 0.48; 95% CI, 0.29-0.78) did not. Parietene (reoperation rate = 1.7%; RR = 2.27; 95% CI, 1.12-4.60; 14 quarters), Surgipro (reoperation rate = 5.0%; RR = 1.92; 95% CI, 1.00-3.72; 9 quarters), and ProLite (reoperation rate = 1.2%; RR = 3.00; 95% CI, 0.31-28.64; 26 quarters) also triggered alerts. CONCLUSIONS AND RELEVANCE: In this cohort study, the DELTA methodology, applied retrospectively, triggered safety alerts for several inguinal hernia repair meshes warranting further investigation. This surveillance system may offer the opportunity for automated monitoring of mesh implants in a postmarket setting.
引用
- Brill ER, Chan PH, Chang RN, et al. Postmarket Surveillance of Mesh Performance After Inguinal Hernia Repair. JAMA Surg. 2025. PMID: 41160017. doi:10.1001/jamasurg.2025.4543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。